Most-cited are based on citations from 2021 ~ 2023.
-
Guideline
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401.
-
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705.
-
Reviews
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
- Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
- Clin Mol Hepatol. 2021;27(2):257-269.
-
Original Articles
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
- Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon
- Clin Mol Hepatol. 2021;27(1):157-174.
-
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
- Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
- Clin Mol Hepatol. 2021;27(1):110-124.
-
Reviews
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
- Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
- Clin Mol Hepatol. 2021;27(1):70-80.
-
Current understanding of primary biliary cholangitis
- Atsushi Tanaka
- Clin Mol Hepatol. 2021;27(1):1-21.
-
Recent updates on the management of autoimmune hepatitis
- Atsumasa Komori
- Clin Mol Hepatol. 2021;27(1):58-69.
-
Original Articles
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
- Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
- Clin Mol Hepatol. 2022;28(3):483-496.
-
Reviews
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
- Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):150-163.
-
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
- Erica Jennison, Christopher D. Byrne
- Clin Mol Hepatol. 2021;27(1):22-43.
-
Original Articles
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
- Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
- Clin Mol Hepatol. 2022;28(3):565-574.
-
Reviews
Recent advances in nonalcoholic fatty liver disease metabolomics
- Hwi Young Kim
- Clin Mol Hepatol. 2021;27(4):553-559.
-
Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
- Takuji Torimura, Hideki Iwamoto
- Clin Mol Hepatol. 2021;27(2):236-245.
-
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
- Gwyneth Soon, Aileen Wee
- Clin Mol Hepatol. 2021;27(1):44-57.
-
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
- Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):790-801.
-
Original Articles
Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
- Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim
- Clin Mol Hepatol. 2021;27(3):451-462.
-
Reviews
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
- Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim
- Clin Mol Hepatol. 2021;27(3):402-412.
-
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
- Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2021;27(2):221-235.
-
Original Articles
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):841-850.
-
Guideline
KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331.
-
Original Articles
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732.
-
Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
- Chung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Cheng-Ting Hsu, Po-Yao Hsu, Hung-Yin Liu, Ying-Chou Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
- Clin Mol Hepatol. 2021;27(1):136-143.
-
Reviews
Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
- Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
- Clin Mol Hepatol. 2022;28(1):17-30.
-
Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
- Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
- Clin Mol Hepatol. 2021;27(4):524-534.
-
Original Articles
Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
- Jeong Won Jang, Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Lewis R. Roberts
- Clin Mol Hepatol. 2021;27(1):207-218.
-
Reviews
Changes in the epidemiology and management of bacterial infections in cirrhosis
- Salvatore Piano, Marta Tonon, Paolo Angeli
- Clin Mol Hepatol. 2021;27(3):437-445.
-
RNA interference as a novel treatment strategy for chronic hepatitis B infection
- Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2022;28(3):408-424.
-
Original Articles
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2022;28(4):890-911.
-
Snapshot
Hepatocellular carcinoma statistics in South Korea
- Young Eun Chon, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2021;27(3):512-514.